InvestorsHub Logo
Followers 3
Posts 852
Boards Moderated 0
Alias Born 12/27/2010

Re: None

Wednesday, 12/28/2011 10:55:39 AM

Wednesday, December 28, 2011 10:55:39 AM

Post# of 48223
I feel like Allezoe is on the brink of something big and is being very hush hush....Is they create New HPV Diagnostic Technology that even slightly works this will pay off major. Sitting tight sure not going to miss this when a huge pr hits the wires.

http://www.allezoe.com/OurCompanies

Allezoe Medical Holdings is in the final stages of discussions to acquire:

* A company that has developed a breakthrough medical technology that will revolutionize the diagnosis and treatment of Human Papillomavirus (HPV), Bovine Papillomavirus (BPV), and potentially cervical cancer.

HPV is the most common sexually transmitted infection and most people who become infected do not know they have it, leading to further spread. Approximately 20 million Americans are infected with HPV — predictions are that 5.5 Million MORE will contract the HPV through sexual contact each year. There are more than 40 types of HPV that can infect the genital areas of both males and females.

The straightforward technology this company has fascinates us, particularly at a time when the number of women with cervical cancer (caused by HPV) is growing worldwide. Cervical cancer is currently the second most common cancer in women and is preventable with the right technologies and treatments.
* A company with state-of-the-art implant technologies for spinal surgery.
This company’s technology aims to facilitate spinal surgery and improve post-surgery quality of life for patients. As the senior population lives longer, and more opt for surgery to ease back pain, we hope to support options that offer them maximum comfort.
* A South Florida-based clinical trial research company.
Clinical trials are where great medical advancements are made, proven, and promoted to the next level. We are eager to be involved in seeing promising solutions to their logical next step.

Allezoe includes Organ Transport Systems, Inc. (OTS), a biomedical company engaged in developing, patenting, and commercializing portable hypothermic, oxygenated preservation and transport technology for human organs. OTS plans to redefine human organ transplantation through better preservation with its LifeCradle® product line.